STOCK TITAN

Zoetis (NYSE: ZTS): Vanguard discloses 10.84% beneficial ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group has disclosed a significant ownership stake in Zoetis Inc. Vanguard reports beneficial ownership of 47,778,909 shares of Zoetis common stock, representing 10.84% of the outstanding class as of the reported date. Vanguard has no sole voting power over these shares but shares voting power over 2,768,187 shares. It reports sole dispositive power, meaning the ability to decide when to sell, over 43,395,509 shares and shared dispositive power over 4,383,400 shares.

The shares are held on behalf of Vanguard’s clients, including registered investment companies and other managed accounts, and no single other person has an interest in more than 5% of the class. Vanguard certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Zoetis.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:01/07/2026

FAQ

What ownership stake in Zoetis Inc (ZTS) does The Vanguard Group report?

The Vanguard Group reports beneficial ownership of 47,778,909 shares of Zoetis Inc common stock, representing 10.84% of the outstanding class as of the reported date.

How much voting power does The Vanguard Group report in Zoetis (ZTS)?

The Vanguard Group reports no sole voting power and shared voting power over 2,768,187 shares of Zoetis common stock.

What dispositive powers does The Vanguard Group have over its Zoetis (ZTS) shares?

The Vanguard Group reports sole dispositive power over 43,395,509 shares and shared dispositive power over 4,383,400 shares of Zoetis common stock.

Are The Vanguard Group’s Zoetis (ZTS) holdings aimed at influencing control of the company?

No. The Vanguard Group certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Zoetis.

On whose behalf does The Vanguard Group hold its Zoetis (ZTS) position?

The shares are held for Vanguard’s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, and no one other person’s interest exceeds 5% of the class.

What type of reporting person is The Vanguard Group in this Zoetis (ZTS) Schedule 13G/A?

The Vanguard Group is classified as an investment adviser (IA) under the reporting categories.

What is the reported event date for The Vanguard Group’s Zoetis (ZTS) ownership?

The date of the event requiring this ownership report is December 31, 2025.

Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

55.46B
440.24M
0.09%
98.66%
1.75%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY